Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Belinsky, S. A.
Right arrow Articles by Byers, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Belinsky, S. A.
Right arrow Articles by Byers, T.
[Cancer Research 66, 3338-3344, March 15, 2006]
© 2006 American Association for Cancer Research


Epidemiology and Prevention

Promoter Hypermethylation of Multiple Genes in Sputum Precedes Lung Cancer Incidence in a High-Risk Cohort

Steven A. Belinsky1, Kieu C. Liechty1, Frederick D. Gentry1, Holly J. Wolf2, Justin Rogers2, Kieu Vu2, Jerry Haney2, Tim C. Kennedy2, Fred R. Hirsch2, York Miller2, Wilbur A. Franklin2, James G. Herman3, Stephen B. Baylin3, Paul A. Bunn2 and Tim Byers2

1 Lovelace Respiratory Research Institute, Albuquerque, New Mexico; 2 University of Colorado Health Sciences Center, Denver, Colorado; and 3 Johns Hopkins University, Baltimore, Maryland

Requests for reprints: Steven A. Belinsky, Lung Cancer Program, Lovelace Respiratory Research Institute, 2425 Ridgecrest Drive Southeast, Albuquerque, NM 87108. Phone: 505-348-9465; Fax: 505-348-4990; E-mail: sbelinsk{at}LRRI.org.

A sensitive screening approach for lung cancer could markedly reduce the high mortality rate for this disease. Previous studies have shown that methylation of gene promoters is present in exfoliated cells within sputum prior to lung cancer diagnosis. The purpose of the current study is to conduct a nested case-control study of incident lung cancer cases from an extremely high-risk cohort for evaluating promoter methylation of 14 genes in sputum. Controls (n = 92) were cohort members matched to cases (n = 98) by gender, age, and month of enrollment. The comparison of proximal sputum collected within 18 months to >18 months prior to diagnosis showed that the prevalence for methylation of gene promoters increased as the time to lung cancer diagnosis decreased. Six of 14 genes were associated with a >50% increased lung cancer risk. The concomitant methylation of three or more of these six genes was associated with a 6.5-fold increased risk and a sensitivity and specificity of 64%. This is the first study to prospectively examine a large panel of genes for their ability to predict lung cancer and shows the promise of gene promoter hypermethylation in sputum as a molecular marker for identifying people at high risk for cancer incidence. (Cancer Res 2006; 66(6): 3338-44)




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Brait, J. G. Ford, S. Papaiahgari, M. A. Garza, J. I. Lee, M. Loyo, L. Maldonado, S. Begum, L. McCaffrey, M. Howerton, et al.
Association between Lifestyle Factors and CpG Island Methylation in a Cancer-Free Population
Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 2984 - 2991.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Yazici, M. B. Terry, Y. H. Cho, R. T. Senie, Y. Liao, I. Andrulis, and R. M. Santella
Aberrant Methylation of RASSF1A in Plasma DNA Before Breast Cancer Diagnosis in the Breast Cancer Family Registry
Cancer Epidemiol. Biomarkers Prev., October 1, 2009; 18(10): 2723 - 2725.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. Cao, J. Zhou, Y. Gao, L. Gu, H. Meng, H. Liu, and D. Deng
Methylation of p16 CpG Island Associated with Malignant Progression of Oral Epithelial Dysplasia: A Prospective Cohort Study
Clin. Cancer Res., August 15, 2009; 15(16): 5178 - 5183.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
V. J. Bailey, H. Easwaran, Y. Zhang, E. Griffiths, S. A. Belinsky, J. G. Herman, S. B. Baylin, H. E. Carraway, and T.-H. Wang
MS-qFRET: A quantum dot-based method for analysis of DNA methylation
Genome Res., August 1, 2009; 19(8): 1455 - 1461.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Tessema, Y. Y. Yu, C. A. Stidley, E. O. Machida, K. E. Schuebel, S. B. Baylin, and S. A. Belinsky
Concomitant promoter methylation of multiple genes in lung adenocarcinomas from current, former and never smokers
Carcinogenesis, July 1, 2009; 30(7): 1132 - 1138.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
R Ghosal, P Kloer, and K E Lewis
A review of novel biological tools used in screening for the early detection of lung cancer
Postgrad. Med. J., July 1, 2009; 85(1005): 358 - 363.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. T. McCabe, J. C. Brandes, and P. M. Vertino
Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications
Clin. Cancer Res., June 15, 2009; 15(12): 3927 - 3937.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
D. M.E.I. Hellebrekers, M. H.F.M. Lentjes, S. M. van den Bosch, V. Melotte, K. A.D. Wouters, K. L.J. Daenen, K. M. Smits, Y. Akiyama, Y. Yuasa, S. Sanduleanu, et al.
GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer
Clin. Cancer Res., June 15, 2009; 15(12): 3990 - 3997.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. Verri, L. Roz, D. Conte, T. Liloglou, A. Livio, A. Vesin, A. Fabbri, F. Andriani, C. Brambilla, L. Tavecchio, et al.
Fragile Histidine Triad Gene Inactivation in Lung Cancer: The European Early Lung Cancer Project
Am. J. Respir. Crit. Care Med., March 1, 2009; 179(5): 396 - 401.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. L. Ostrow, H. L. Park, M. O. Hoque, M. S. Kim, J. Liu, P. Argani, W. Westra, W. V. Criekinge, and D. Sidransky
Pharmacologic Unmasking of Epigenetically Silenced Genes in Breast Cancer
Clin. Cancer Res., February 15, 2009; 15(4): 1184 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
W. K. DE JONG, G. F. VERPOOTEN, H. KRAMER, J. LOUWAGIE, and H. J.M. GROEN
Promoter Methylation Primarily Occurs in Tumor Cells of Patients with Non-small Cell Lung Cancer
Anticancer Res, January 1, 2009; 29(1): 363 - 369.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. Tessema and S. A. Belinsky
Mining the Epigenome for Methylated Genes in Lung Cancer
Proceedings of the ATS, December 1, 2008; 5(8): 806 - 810.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
Y. E. Miller
Minimizing Unintended Consequences of Detecting Lung Nodules by Computed Tomography
Am. J. Respir. Crit. Care Med., November 1, 2008; 178(9): 891 - 892.
[Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
K. Steiling, J. Ryan, J. S. Brody, and A. Spira
The Field of Tissue Injury in the Lung and Airway
Cancer Prevention Research, November 1, 2008; 1(6): 396 - 403.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. S. Herbst, J. V. Heymach, and S. M. Lippman
Lung Cancer
N. Engl. J. Med., September 25, 2008; 359(13): 1367 - 1380.
[Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
J.-P. Issa
Cancer Prevention: Epigenetics Steps Up to the Plate
Cancer Prevention Research, September 1, 2008; 1(4): 219 - 222.
[Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
D. Sidransky
The Oral Cavity as a Molecular Mirror of Lung Carcinogenesis
Cancer Prevention Research, June 1, 2008; 1(1): 12 - 14.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
J. D.F. Licchesi, W. H. Westra, C. M. Hooker, and J. G. Herman
Promoter Hypermethylation of Hallmark Cancer Genes in Atypical Adenomatous Hyperplasia of the Lung
Clin. Cancer Res., May 1, 2008; 14(9): 2570 - 2578.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Leng, C. A. Stidley, R. Willink, A. Bernauer, K. Do, M. A. Picchi, X. Sheng, M. A. Frasco, D. Van Den Berg, F. D. Gilliland, et al.
Double-Strand Break Damage and Associated DNA Repair Genes Predispose Smokers to Gene Methylation
Cancer Res., April 15, 2008; 68(8): 3049 - 3056.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Baryshnikova, A. Destro, M. V. Infante, S. Cavuto, U. Cariboni, M. Alloisio, G. L. Ceresoli, R. Lutman, G. Brambilla, G. Chiesa, et al.
Molecular Alterations in Spontaneous Sputum of Cancer-Free Heavy Smokers: Results from a Large Screening Program
Clin. Cancer Res., March 15, 2008; 14(6): 1913 - 1919.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
M. V. Brock, C. M. Hooker, E. Ota-Machida, Y. Han, M. Guo, S. Ames, S. Glockner, S. Piantadosi, E. Gabrielson, G. Pridham, et al.
DNA Methylation Markers and Early Recurrence in Stage I Lung Cancer
N. Engl. J. Med., March 13, 2008; 358(11): 1118 - 1128.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
T. Byers, H. J. Wolf, W. A. Franklin, S. Braudrick, D. T. Merrick, K. R. Shroyer, F. R. Hirsch, C. Zeng, A. E. Baron, P. A. Bunn, et al.
Sputum Cytologic Atypia Predicts Incident Lung Cancer: Defining Latency and Histologic Specificity
Cancer Epidemiol. Biomarkers Prev., January 1, 2008; 17(1): 158 - 162.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. L. Carvalho, C. Jeronimo, M. M. Kim, R. Henrique, Z. Zhang, M. O. Hoque, S. Chang, M. Brait, C. S. Nayak, W.-W. Jiang, et al.
Evaluation of Promoter Hypermethylation Detection in Body Fluids as a Screening/Diagnosis Tool for Head and Neck Squamous Cell Carcinoma
Clin. Cancer Res., January 1, 2008; 14(1): 97 - 107.
[Abstract] [Full Text] [PDF]


Home page
J. Mol. Diagn.Home page
K. S. Gustafson
Locked Nucleic Acids Can Enhance the Analytical Performance of Quantitative Methylation-Specific Polymerase Chain Reaction
J. Mol. Diagn., January 1, 2008; 10(1): 33 - 42.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Zou, J. J. Harrington, A. M. Shire, R. L. Rego, L. Wang, M. E. Campbell, A. L. Oberg, and D. A. Ahlquist
Highly Methylated Genes in Colorectal Neoplasia: Implications for Screening
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2686 - 2696.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Y. E. Miller, P. Blatchford, D. S. Hyun, R. L. Keith, T. C. Kennedy, H. Wolf, T. Byers, P. A. Bunn Jr., M. T. Lewis, W. A. Franklin, et al.
Bronchial Epithelial Ki-67 Index Is Related to Histology, Smoking, and Gender, but Not Lung Cancer or Chronic Obstructive Pulmonary Disease
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2425 - 2431.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
R. L. Sedjo, T. Byers, E. Barrera Jr., C. Cohen, E. T. H. Fontham, L. A. Newman, C. D. Runowicz, A. G. Thorson, M. J. Thun, E. Ward, et al.
A Midpoint Assessment of the American Cancer Society Challenge Goal to Decrease Cancer Incidence by 25% Between 1992 and 2015
CA Cancer J Clin, November 1, 2007; 57(6): 326 - 340.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. M. Lippman and J. V. Heymach
The Convergent Development of Molecular-Targeted Drugs for Cancer Treatment and Prevention
Clin. Cancer Res., July 15, 2007; 13(14): 4035 - 4041.
[Abstract] [Full Text] [PDF]


Home page
International Journal of ToxicologyHome page
H.-J. Haussmann
Smoking and Lung Cancer: Future Research Directions
International Journal of Toxicology, July 1, 2007; 26(4): 353 - 364.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Dubey and C. A. Powell
Update in Lung Cancer 2006
Am. J. Respir. Crit. Care Med., May 1, 2007; 175(9): 868 - 874.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
Y.-J. Zhang, H.-C. Wu, J. Shen, H. Ahsan, W. Y. Tsai, H.-I Yang, L.-Y. Wang, S.-Y. Chen, C.-J. Chen, and R. M. Santella
Predicting Hepatocellular Carcinoma by Detection of Aberrant Promoter Methylation in Serum DNA
Clin. Cancer Res., April 15, 2007; 13(8): 2378 - 2384.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. V. Karamouzis, P. A. Konstantinopoulos, and A. G. Papavassiliou
The Activator Protein-1 Transcription Factor in Respiratory Epithelium Carcinogenesis
Mol. Cancer Res., February 1, 2007; 5(2): 109 - 120.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Guo, J. Ren, M. G. House, Y. Qi, M. V. Brock, and J. G. Herman
Accumulation of Promoter Methylation Suggests Epigenetic Progression in Squamous Cell Carcinoma of the Esophagus
Clin. Cancer Res., August 1, 2006; 12(15): 4515 - 4522.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.